Market Review: May 19, 2026

Closing Recap

Tuesday, May 19, 2026

US equity futures faded again overnight as investors continue to work through an array of factors generating uncertainty: inflation, the next move on rates from the Fed, Iran negotiations or back on the offensive, earnings. At least on the earnings front, the news generally has been good, but that tailwind is beginning to die off as the season slows. That said, we still have some big names left to report, think NVDA, so the earnings theme may not be totally dead yet. In sentiment today, as equities continued to fade, the Fear and Greed Index still registered 61/100 (Greed) versus last week’s 65 (Greed) and last month’s 68 (Greed). Early breadth favored decliners by almost 3:1 as small caps underperformed with IWM (-1.85%) versus SPY (-0.92%) and QQQ (-1.24%). SPY breadth favoring decliners by 11:9, but QQQ breadth was about neutral. Sector performance also was tilted negative. Health Care (+1.28%), Consumer Staples (+0.58%) and Utilities (+0.20%) were early outperformers among S&P sector ETFs, while Industrials (-1.41%), Consumer Discretionary (-1.59%) and Materials (-2.60%) paced the underperformers with four sectors gaining versus seven declining.

In data of note today, 10-year Treasury yields now stand near 4.7% and have gained over 70bps since the beginning of the Iran war per @bespokeinvest. On concentration, once again the S&P 500 has never been more concentrated. Per @PeterMallouk, NVDA and AAPL now represent over 15% of the index. Lastly, on timing, per @DataTrekMB, the S&P 500 has posted weaker compounded returns over the June-October period versus January-May or November-December but staying invested has produced superior returns over the long term so seasonal timing has not been the optimal strategy.

Heading into the final hour of trading for the day, US equities retreated from a midday bounce led by declines in financials, industrials materials and technology, off the lows but also off the highs. Risk sentiment recovered throughout Tuesday as Treasury yields erased some of their early increases and oil fell, giving equities room to largely recover morning losses. Momentum outperformed quality, semiconductors recovered throughout the day after the SOX Index had neared correction territory (semi bounce led to software selling), and value marginally beat growth. The market waits for new inflation data, new Iran headlines and NVDA. Until then, it could be a mostly sideways slog as investors look forward to Summer.

Asset allocators increased their equity exposure to stocks by the most on record to a net 50% overweight from 13% last month, and are now most overweight stocks since January 2022, Bank of America’s Global Fund Manager Survey shows. The most crowded trade, referenced by 73% of respondents, is long semiconductors, followed by long Mag-7 (14%) and long oil (6%). https://tinyurl.com/ys6ttyc5

• Japan’s preliminary Q1 GDP expanded 2.1% QoQ annualized vs forecast 1.6%. However, the better-than-expected headline number partially reflected a low base effect from a downward revision to Q4 which was cut to 0.8% from 1.3%.

•  WTI crude slipped overnight then continued to fade early in the session as no market-moving Iran headlines emerged to take control of the price action. No news of an imminent strike was sufficient for investors to institute a buying pause, at least for today. July WTI crude figures settled well off the lows, -$0.23/bbl, or -0.22%, at $104.15.

• Home Improvement Retail: Dow component HD reported Q1 sales $41.77B top consensus $41.52B; Q1 adj EPS $3.43 vs. consensus $3.41; Q1 comp sales rose +0.6% vs. est. +0.9%; reaffirms 2026 view of total sales growth of 2.5%-4.5%, comparable sales growth of approximately flat to 2.0% and gross margin of approximately 33.1%.
• Building Products/Materials: EXP Q4 EPS $1.91 topped consensus $1.54 and revs rose 2% y/y to $479.1M above consensus $451.98M as higher cement sales volume, driven by public infrastructure and private non-residential construction activity, supported Q4 results; said sees continued near-term demand uncertainty due to evolving geopolitical and policy conditions.

• Leisure sector: STUB was upgraded to Buy from Neutral at Guggenheim and raise tgt to $12.50 from $8.50 representing ~30% potential upside to yesterday’s close saying Stub has reset Street expectations for this year and next year and the bar is extremely low on Direct Issuance and Advertising, therefore any progress would represent upside optionality.

• In Transports: in logistics, @FreightAlley noted on X, “Daily truckload spot rates bounce back yesterday to road check levels of $3.55/mile. This is happening despite DOT Roadcheck ending on Thursday of last week. It suggests that drivers took off last week and are not returning before the Memorial Day holiday. This is the 3rd highest level this cycle and demonstrates just how tight trucking capacity really is. Could we hit a new all-time record before the week is up? (logistics KNX, WERN, ODFL, JBHT). RXO provides update, including improved outlook for truckload gross profit per load/expects may truckload gross profit per load to outperform seasonality.

• In Insurance: PFG downgraded to Outperform from Strong Buy at Raymond James following management meetings saying valuation is full; THG was downgraded to Market Perform from Outperform with $203 PT at BMO Capital, taking profits when THG is hitting on all cylinders saying valuation multiples are nearing fair value for many insurers, including THG which exhibits a larger than peer-average home Insurance portfolio. JRVR was downgraded to Neutral from Buy at UBS and cut tgt to $4.75 from $8 driven by a higher equity cost of capital given the increased risks it sees for adverse reserve development hitting the P&L and Book Value.

• RLAY announces initial clinical data from Phase 2 ReInspire trial of zovegalisib in vascular anomalies signaling advantage of PI3Kα mutant-selective inhibition. Of the 32 patients enrolled, 20 have been evaluated for efficacy per volumetric response assessment by blinded independent central review (BICR).
• The White House said yesterday that it’s adding more than 600 generic drugs to the TrumpRx website, which directs patients to cash-pay drug offerings. The administration is not creating new offerings; it’s updated the website to include generic drugs available through other websites like Mark Cuban’s Cost Plus Drug Company and Amazon Pharmacy.

• In Software: the group has bounced the last few days with some profit taking in semiconductors (SOX) after a monster run that saw the SOX rise as much as 71% YTD (now +57% YTD) and tech money rolled into software names (NOW, MSFT, TEAM, MNDY, CRWD, PANW, ZS, WDAY, DDOG, etc.); AGYS shares jumped on results and guidance as Q4 adj EPS $0.63 vs. est. $0.50; Q4 revs $82.9M vs. est. $81.56M; sees FY27 revenue $365M-$370M, vs. consensus $363.59M and sees FY27 adjusted EBITDA 24% of revenue.
• EDA Sector: Bank America previewed the sector ahead of earnings saying semi R&D reacceleration not in CDNS outlooks, creating upside as Ai, custom silicon and adv. packaging lift EDA reliance. 2030 EPS power suggests meaningful upside: CDNS $17 and SNPS $34 if sales track 15% semi R&D CAGR with operating leverage. The firm said SNPS has more upside catalysts, but CDNS remains top pick on execution, TSM exposure, HW/IP strength and China momentum.
• In Towers: AMT was upgraded to Outperform from Market Perform at Bernsten with an unchanged price target of $207 as believes the market is overstating American Tower’s risk while undervaluing its potential upside. With the stock at a five year low multiple, this is the moment to buy the shares the firm said.

• GTM was reinstated at Underperform at Bank America and a $4 PT saying advances in AI are lowering the barriers that once protected ZoomInfo’s dominance and position as a premium-priced vendor. GTM’s planned shift towards consumption-based pricing in 2H26 also lowers NT visibility and introduces higher down-sell risk.
• MRAM shares dropped after short seller Kerrisdale Capital said they were short shares of the $900M niche industrial memory chipmaker whose stock has soared 300% in a matter of weeks.
• SITM announces proposed $1.1B convertible senior notes offering.
• STX shares fell sharply Monday and again today after management’s comments at the JP Morgan conference raised concerns about meeting memory chip demand.